Carlos Iribarren to Double-Blind Method
This is a "connection" page, showing publications Carlos Iribarren has written about Double-Blind Method.
Connection Strength
0.140
-
Cardiovascular and cerebrovascular events among patients receiving omalizumab: Pooled analysis of patient-level data from 25 randomized, double-blind, placebo-controlled clinical trials. J Allergy Clin Immunol. 2017 05; 139(5):1678-1680.
Score: 0.140